Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Metastatic Breast Cancer
100%
Synergize
100%
Tumor Antigen Presentation
100%
Anti-PD-1 Therapy
100%
Breast Cancer
50%
Small Molecules
25%
T Cell Response
25%
Poor Prognosis
25%
Viable Approach
25%
Metastasis
25%
Messenger RNA (mRNA)
25%
T Cell Activation
25%
Combination Therapy
25%
Immune Surveillance
25%
Staphylococcal nuclease
25%
Metadherin
25%
Pharmacological Targeting
25%
Therapy Resistance
25%
T Cell Infiltration
25%
Antitumor T Cells
25%
Overall Survival Rate
25%
Therapy Response
25%
Immune Checkpoint Therapy
25%
Genetic Targeting
25%
Antigen Presentation Machinery
25%
Anti-programmed Cell Death Protein 1 (anti-PD-1)
25%
Medicine and Dentistry
Metastatic Breast Cancer
100%
Antigen Presentation
100%
Tumor Antigen
100%
Breast Cancer
50%
T Cell
25%
Cell Activation
25%
Immunosurveillance
25%
Overall Survival
25%
Treatment Response
25%
Combination Therapy
25%
Survival Rate
25%
Therapy Resistance
25%
T-Cell Response
25%
Immune Checkpoint Blockade
25%
Cellular Infiltration
25%
Programmed Death 1 Receptor
25%
Messenger RNA
25%
Genetics
25%
Micrococcal Nuclease
25%
Biochemistry, Genetics and Molecular Biology
Antigen Presentation
100%
Tumor Antigen
100%
T Cell
66%
Small Molecule
33%
Genetics
33%
Cell Death
33%
Synapsin I
33%
Micrococcal Nuclease
33%
Cell Activation
33%
Immunosurveillance
33%
Overall Survival
33%
Survival Rate
33%
Cell Infiltration
33%
Immune Checkpoints
33%
Messenger RNA
33%
Immunology and Microbiology
Antigen Presentation
100%
Tumor Antigen
100%
T Cell
66%
Nuclease
33%
Immunosurveillance
33%
Cell Activation
33%
Survival Rate
33%
Overall Survival
33%
Cell Infiltration
33%
Immune Checkpoint Blockade
33%
Ribonucleic Acid
33%
Programmed Death 1 Receptor
33%